BAFNA PHARMACEUTICALS LTD.

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
INCOME :
Sales Turnover	43.36	47.17	64.96	86.39	98.59
Other Income	1.66	31.33	1.14	1.98	46.01
Stock Adjustments	-0.81	-4.09	3.09	0.65	-12.17
Total Income	44.21	74.41	69.19	89.02	132.43
EXPENDITURE :
Raw Materials	27	34.19	55.01	66.73	69.51
Excise Duty	0	0	0	1.07	0.92
Power and Fuel Cost	2.5	2.13	2.05	2.54	2.01
Other Manufacturing Expenses	4.48	3.55	3.9	4.43	8.12
Employee Cost	9.01	7.47	6.81	6.99	10.78
Selling and Administration Expenses	3.13	4.04	3.2	3.39	9.17
Miscellaneous Expenses	9.77	26.82	2.9	1.38	6.42
Less: Preoperative Expenditure Capitalised	0	0	0	0	0
Profit before Interest, Depreciation and Tax	-11.68	-3.8	-4.67	2.5	25.51
Interest and Financial Charges	2.13	6.94	11.47	12.96	13.46
Profit before Depreciation and Tax	-13.81	-10.74	-16.14	-10.46	12.05
Depreciation	3.48	3.97	4.22	4.86	5.99
Minority Interest before PAT	0	0	0	0	0
Profit Before Tax	-17.28	-14.72	-20.36	-15.32	6.07
Tax	1.07	2.19	-0.9	-0.18	-0.15
Profit After Tax	-18.35	-16.91	-19.46	-15.14	6.22
Minority Interest after PAT	0.52	-0.17	-0.37	-1.11	0.04
Profit/Loss of Associate Company	0	0	0	0	0
Profit after Minority Interest and P/L of Assoc. Co.	-18.87	-16.74	-19.09	-14.03	6.18
Adjustment below Net Profit	0	0	0	0	-3.26
P and L Balance brought forward	-34.58	-17.85	1.24	15.27	12.96
Appropriations	0	0	0	0	0.61
P and L Bal. carried down	-53.45	-34.58	-17.85	1.24	15.27
Equity Dividend	0	0	0	0	0
Preference Dividend	0	0	0	0	0
Corporate Dividend Tax	0	0	0	0	0
Equity Dividend (%)	0	0	0	0	0
Earning Per Share (Rs.)	0	0	0	0	3.31
Book Value	8.06	16.03	20.73	30.96	38.47
Extraordinary Items	1.01	27.84	0	0	36.02

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

INCOME :

Sales Turnover

43.36

47.17

64.96

86.39

98.59

Other Income

1.66

31.33

1.14

1.98

46.01

Stock Adjustments

-0.81

-4.09

3.09

0.65

-12.17

Total Income

44.21

74.41

69.19

89.02

132.43

EXPENDITURE :

Raw Materials

34.19

55.01

66.73

69.51

Excise Duty

1.07

0.92

Power and Fuel Cost

2.5

2.13

2.05

2.54

2.01

Other Manufacturing Expenses

4.48

3.55

3.9

4.43

8.12

Employee Cost

9.01

7.47

6.81

6.99

10.78

Selling and Administration Expenses

3.13

4.04

3.2

3.39

9.17

Miscellaneous Expenses

9.77

26.82

2.9

1.38

6.42

Less: Preoperative Expenditure Capitalised

Profit before Interest, Depreciation and Tax

-11.68

-3.8

-4.67

2.5

25.51

Interest and Financial Charges

2.13

6.94

11.47

12.96

13.46

Profit before Depreciation and Tax

-13.81

-10.74

-16.14

-10.46

12.05

Depreciation

3.48

3.97

4.22

4.86

5.99

Minority Interest before PAT

Profit Before Tax

-17.28

-14.72

-20.36

-15.32

6.07

Tax

1.07

2.19

-0.9

-0.18

-0.15

Profit After Tax

-18.35

-16.91

-19.46

-15.14

6.22

Minority Interest after PAT

0.52

-0.17

-0.37

-1.11

0.04

Profit/Loss of Associate Company

Profit after Minority Interest and P/L of Assoc. Co.

-18.87

-16.74

-19.09

-14.03

6.18

Adjustment below Net Profit

-3.26

P and L Balance brought forward

-34.58

-17.85

1.24

15.27

12.96

Appropriations

0.61

P and L Bal. carried down

-53.45

-34.58

-17.85

1.24

15.27

Equity Dividend

Preference Dividend

Corporate Dividend Tax

Equity Dividend (%)

Earning Per Share (Rs.)

3.31

Book Value

8.06

16.03

20.73

30.96

38.47

Extraordinary Items

1.01

27.84

36.02

	2019 ( ₹ in Cr. )	2018 ( ₹ in Cr. )	2017 ( ₹ in Cr. )	2016 ( ₹ in Cr. )	2015 ( ₹ in Cr. )
SOURCES OF FUNDS :
Share Capital	23.66	23.66	18.66	18.66	18.66
Reserves and Surplus	-4.6	14.27	24.01	39.1	53.12
Total Shareholders Funds	19.06	37.93	42.67	57.76	71.78
Secured Loans	44.1	44.37	80.14	80.48	68.65
Unsecured Loans	2.76	15.12	15.03	0.92	0.39
Total Debt	46.86	59.49	95.17	81.4	69.04
Minority Interest	-0.21	-0.73	-0.55	0	0.93
Total Liabilities	65.71	96.69	137.29	139.16	141.75
APPLICATION OF FUNDS :
Gross Block	80.11	79.77	79.65	79.67	77.36
Less: Accum. Depreciation	43.05	34.88	31.04	27.06	22.8
Net Block	37.06	44.89	48.61	52.61	54.56
Capital Work in Progress	0	0	0	0	0
Investments	0	0	16.9	16.9	16.9
Current Assets, Loans and Advances
Inventories	9.28	10.67	16.74	16.38	16.12
Sundry Debtors	24.83	24.28	53.78	67.96	88.69
Cash and Bank Balance	2.71	2.95	2.66	2.71	2.77
Loans and Advances	45.59	55.56	39.62	36.14	20.79
Less: Current Liab. and Prov.
Current Liabilities	53.76	41.67	41.02	53.56	58.07
Provisions	0	0	0	0	0
Net Current Assets	28.65	51.79	71.78	69.63	70.3
Miscellaneous Expenses not w/o	0	0	0	0	0
Total Assets	65.71	96.68	137.29	139.14	141.76
Contingent Liabilities	0	0	0.29	1.64	11.56

2019 ( ₹ in Cr. )

2018 ( ₹ in Cr. )

2017 ( ₹ in Cr. )

2016 ( ₹ in Cr. )

2015 ( ₹ in Cr. )

SOURCES OF FUNDS :

Share Capital

23.66

18.66

Reserves and Surplus

-4.6

14.27

24.01

39.1

53.12

Total Shareholders Funds

19.06

37.93

42.67

57.76

71.78

Secured Loans

44.1

44.37

80.14

80.48

68.65

Unsecured Loans

2.76

15.12

15.03

0.92

0.39

Total Debt

46.86

59.49

95.17

81.4

69.04

Minority Interest

-0.21

-0.73

-0.55

0.93

Total Liabilities

65.71

96.69

137.29

139.16

141.75

APPLICATION OF FUNDS :

Gross Block

80.11

79.77

79.65

79.67

77.36

Less: Accum. Depreciation

43.05

34.88

31.04

27.06

22.8

Net Block

37.06

44.89

48.61

52.61

54.56

Capital Work in Progress

Investments

16.9

Current Assets, Loans and Advances

Inventories

9.28

10.67

16.74

16.38

16.12

Sundry Debtors

24.83

24.28

53.78

67.96

88.69

Cash and Bank Balance

2.71

2.95

2.66

2.71

2.77

Loans and Advances

45.59

55.56

39.62

36.14

20.79

Less: Current Liab. and Prov.

Current Liabilities

53.76

41.67

41.02

53.56

58.07

Provisions

Net Current Assets

28.65

51.79

71.78

69.63

70.3

Miscellaneous Expenses not w/o

Total Assets

65.71

96.68

137.29

139.14

141.76

Contingent Liabilities

0.29

1.64

11.56

BAFNA PHARMACEUTICALS LTD.

Enjoy Lifetime Free Delivery Trade